Tianjin Tianyao Pharmaceuticals Co., Ltd

Short Term Long Term Short Term Comparison Long Term Comparison
  • 600488
  • 1d-1.28%
  • 1w-2.27%
  • 1m-4.44%
  • 1y-16.44%
ATH
  • ATH Price$12.70
  • ATH Date2015-06-18
  • % since ATH-69.54%
  • % to ATH228.26%
ATL
  • ATL Price$0.89
  • ATL Date2005-03-30
  • % from ATL332.98%
  • Last Low Price$3.28
  • Last Low Date2024-02-07
  • % From Last Low17.99%
IPO
  • IPO Price$28.99
  • % Current ROI USD-86.65%
  • ATH Price$12.70
  • % ROI ATH 142,129.11%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="600488"]

Key Data [addtoany]

Current price $3.87
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Today's High/Low $3.95/$3.74
Volume 5,230,200.00
Previous Close $3.92
52 Week High/Low $6.26/$3.1
Market Cap 4,288,205,568.00
P/E Ratio 35.6364
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0.0026
$3.87
[addtoany]

Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research, manufacture, and export of pharmaceutical APIs in Asia. It primarily provides corticosteroid, cardio cerebrovascular, and analgesic APIs and formulations. The company offers bulk drugs, including dexamethasone, dexamethasone sodium phosphate, dexamethasone acetate, triamcinlone acetonide acetate, prednisone acetate, prednisone, prednisolone, flucinonide, halcinonide, triamcinolone acetonide, clobetasol propionate, betamethasone, methylprednisolone hydrocortisone acetate, methylprednisolone, and triamcinolone. The company is based in Tianjin, China. Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHSE : 600488) operates as a subsidiary of Jinhushen Biomedical Technology Co., Ltd.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity